Companies / Slovenia
Krka, Servier Settle Patent Dispute
November 2006 | Legal NewsSlovenia's Krka has reached an out-of-court settlement with French firm Servier over a generic version of the latter's perindopril - an ACE inhibitor for the treatment of hypertension. Under the deal, Krka will be able to market Prenessa in several Eastern European countries, although not in the lucrative UK market. It is BMI's view that the earlier than expected resolution of the issue is positive for both parties because litigation is a drain on both time and money.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
